Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RABITO: RFA vs Radioactive Iodine for Hyperthyroidism
NCT05142904Phase 3Terminated
- Sponsor
- Rijnstate
- Start
- Nov 2021
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hyperthyroidism and autonomously functioning thyroid nodule (AFTN) (3 arms), sponsored by Rijnstate. Primary endpoint: Hypothyroidism at 1 year. Started Nov 2021; status: terminated.
02
Conditions
hyperthyroidismautonomously functioning thyroid nodule (AFTN)
Beyond the preview
Go deeper on NCT05142904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05142904.